These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18612559)

  • 1. Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Jul; 100(1):168-9; author reply 169-70. PubMed ID: 18612559
    [No Abstract]   [Full Text] [Related]  

  • 2. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 3. HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux-induced HIT.
    Warkentin TE; Sheppard JA; Manheim JC
    Thromb Haemost; 2014 Dec; 112(6):1319-22. PubMed ID: 25319237
    [No Abstract]   [Full Text] [Related]  

  • 4. Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
    Pistulli R; Oberle V; Figulla HR; Yilmaz A; Pfeifer R
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):76-8. PubMed ID: 21076279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.
    Warkentin TE; Sheppard JI; Sun JC; Jung H; Eikelboom JW
    J Thromb Haemost; 2013 Feb; 11(2):253-60. PubMed ID: 23216710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
    Warkentin TE; Davidson BL; Büller HR; Gallus A; Gent M; Lensing AWA; Piovella F; Prins MH; Segers AEM; Kelton JG
    Chest; 2011 Aug; 140(2):366-373. PubMed ID: 21393394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to the diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE
    Chest; 2005 Feb; 127(2 Suppl):35S-45S. PubMed ID: 15706029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.
    Pandya KA; Johnson EG; Davis GA; Padmanabhan A
    Thromb Res; 2018 Dec; 172():169-171. PubMed ID: 30419472
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia in the ICU: an overview.
    Sakr Y
    Crit Care; 2011; 15(2):211. PubMed ID: 21457505
    [No Abstract]   [Full Text] [Related]  

  • 18. The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by "true" heparin-induced thrombocytopenia.
    Warkentin TE; Moore JC; Vogel S; Sheppard JA; Warkentin NI; Eikelboom JW
    Thromb Haemost; 2012 May; 107(5):998-1000. PubMed ID: 22371139
    [No Abstract]   [Full Text] [Related]  

  • 19. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin-induced thrombocytopenia (HIT).
    Warkentin TE; Sheppard JI
    J Thromb Haemost; 2007 Mar; 5(3):636-7. PubMed ID: 17155944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.